Amino acid metabolism in breast cancer: pathogenic drivers and therapeutic opportunities
Protein & Cell · 19.07.2025 · 16 (7) · 506-531
DOI: 10.1093/procel/pwaf011 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Protein & Cell, online erschienen am 20.02.2025. Verfasst von Yawen Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Shanghai Sixth People's Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, …. Hauptthemen laut MEDLINE: Breast Neoplasms, Amino Acids. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Amino acid metabolism plays a critical role in the progression and development of breast cancer. Cancer cells, including those in breast cancer, reprogram amino acid metabolism to meet the demands of rapid proliferation, survival, and immune evasion. This includes alterations in the uptake and utilization of amino acids, such as glutamine, serine, glycine, and arginine, which provide essential building blocks for biosynthesis, energy production, and redox homeostasis. Notably, the metabolic phenotypes of breast cancer cells vary across molecular subtypes and disease stages, emphasizing the need for patient stratification and personalized therapeutic strategies. Advances in multi-level diagnostics, including phenotyping and predictive tools, such as AI-based analysis and body fluid profiling, have highlighted the potential for tailoring treatments to individual metabolic profiles. Enzymes, such as glutaminase and serine hydroxymethyltransferase, often upregulated in breast cancer, represent promising therapeutic targets. Understanding the interplay between amino acid metabolism and breast cancer biology, alongside the integration of personalized medicine approaches, can uncover novel insights into tumor progression and guide the development of precision therapies. This review explores the metabolic pathways of amino acids in breast cancer, with a focus on their implications for personalized treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Shanghai Sixth People's Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
- Department of Breast Surgery, Shanghai Sixth People's Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
- Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), Universidad de Sevilla-CSIC-Universidad Pablo de Olavide, Seville 41004, Spain.
ORCID-Profile: Yawen Liu, Xiangyun Zong, Patricia Altea-Manzano, Jie Fu
Zitieren
APA
Liu, Y., Zong, X., Altea-Manzano, P., & Fu, J. (2025). Amino acid metabolism in breast cancer: pathogenic drivers and therapeutic opportunities. Protein & Cell, 16(7), 506-531. https://doi.org/10.1093/procel/pwaf011
Vancouver
Liu Y, Zong X, Altea-Manzano P, Fu J. Amino acid metabolism in breast cancer: pathogenic drivers and therapeutic opportunities. Protein & Cell. 2025;16(7):506-531. doi:10.1093/procel/pwaf011
BibTeX
@article{Liu2025,
author = {Liu, Yawen and Zong, Xiangyun and Altea-Manzano, Patricia and Fu, Jie},
title = {Amino acid metabolism in breast cancer: pathogenic drivers and therapeutic opportunities},
journal = {Protein & Cell},
year = {2025},
volume = {16},
number = {7},
pages = {506--531},
doi = {10.1093/procel/pwaf011}
}
EUVIMED